Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Pratice (UK)
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to Atrial Fibrillation
Related studies linked through entity extraction aliases.
Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Pratice (Netherlands)
- Status
- COMPLETED
- Phase
- N/A
Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Practice (Germany)
- Status
- COMPLETED
- Phase
- N/A
Thumb-ECG Ambulant Screening for Atrial Fibrillation in Patients Treated for Hyperthyroidism (TAMBOURINE)
- Status
- TERMINATED
- Phase
- N/A
A CALIBER Study: Risk Factors for Stroke, Heart Failure, and Myocardial Infarction in Atrial Fibrillation
- Status
- UNKNOWN
- Phase
- N/A
Exercise Performance in Patients With Atrial Fibrillation
- Status
- UNKNOWN
- Phase
- N/A
The Effect of Early Repeat Atrial Fibrillation (AF) Ablation on AF Recurrence
- Status
- COMPLETED
- Phase
- NA
Improved Prevention of Stroke in Primary Care in Stockholm, Sweden (Förbättrad Prevention av Stroke)
- Status
- COMPLETED
- Phase
- NA
Apixaban for the Reduction of Thrombo-Embolism in Patients With Device-Detected Sub-Clinical Atrial Fibrillation
- Status
- COMPLETED
- Phase
- PHASE4
GLORIA-AF Registry Program (Phase II/III)
- Status
- COMPLETED
- Phase
- N/A
Adenosine Effect on Persistent Pulmonary Vein Isolation Line Evaluation (APPLE Trial)
- Status
- COMPLETED
- Phase
- PHASE3
Post Market Clinical Follow-up of CRT-DX Therapy With Lumax 640/740 HF-T
- Status
- COMPLETED
- Phase
- N/A
Retrospective Registry Providing Baseline Data on the Outcome of Left Atrial (LA) or LA Appendage (LAA) Thrombus in Patients With Nonvalvular Atrial Fibrillation (AF) or Atrial Flutter After Standard of Care (SoC) Anticoagulant Therapy
- Status
- COMPLETED
- Phase
- N/A
Effectiveness of an Interdisciplinary, Nurse-coordinated Atrial Fibrillation Expert Program for Primary Care Patients
- Status
- UNKNOWN
- Phase
- NA
Improving Stroke Prevention Therapy for Patients With Atrial Fibrillation in Primary Care
- Status
- COMPLETED
- Phase
- NA
Integrated Management Program Advancing Community Treatment of Atrial Fibrillation
- Status
- COMPLETED
- Phase
- NA
Characterization and Elimination of Mother Rotors
- Status
- WITHDRAWN
- Phase
- NA
Risk of Stroke and Silent Cerebrovascular Thromboembolism After Cardioversion of Atrial Fibrillation
- Status
- COMPLETED
- Phase
- PHASE3
Feasibility and Safety Study of LAmbre Left Atrial Appendage Occluder
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Prevention of Atrial Fibrillation by Optimized Overdrive Stimulation
- Status
- COMPLETED
- Phase
- NA